Year: 2024
Type: dissertation
Abstract: Neurodegeneration of retinal ganglion cells (RGCs) lacks effective therapeutics, with no direct current treatments to slow or reverse progression. Supplementation of growth factors can provide a promising approach to treat RGC loss, but have been challenging to translate into clinical treatments. The endogenous growth factor, platelet-derived growth factor (PDGF) can protect RGC neurons against various injury types. However, the underlying mechanism has not been well-characterized. Recent research from the Sivak lab showed that neuroprotection conferred by PDGF isoforms is dependent, in vitro, via a novel interaction between the PI3K signaling pathway and the RNA-binding protein, ZC3H14. Here, we further investigate the neuroprotection conferred by PDGF and this underlying mechanism in an in vivo model of RGC degeneration in wild type and ZC3H14 knockout mice. Characterizations of selected target transcripts of ZC3H14 revealed no significant changes at three hours in knockout mice compared to wild type. However knockout mice exhibited a trend towards reduced AKT phosphorylation downstream of PI3K. Together, these data validate the neuroprotective properties of PDGF and its dependence on ZC3H14 in the mouse retina, and reveal a potential new mechanism to regulated PI3K-AKT signaling.
Source: TSpace (University of Toronto)
Author: D'Ercole, Joseph
Institution: University of Toronto
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7133071316
